Evaluation of the Pharmaceutical Drugs Program / prepared by the Office of Audit and Evaluation, Health Canada and the Public Health Agency of Canada. : H14-620/2024E-PDF
"Covering activities from 2017-18 to 2022-23, the evaluation examined pharmaceutical drugs for human and veterinary use, including both prescription and non-prescription drugs. Activities related to biologics, radiopharmaceuticals, natural health products and medical devices were excluded from this evaluation, as there are separately planned evaluations to assess these other health products"--page iii.
Lien permanent pour cette publication :
publications.gc.ca/pub?id=9.939161&sl=1
| Ministère/Organisme | Canada. Health Canada, issuing body. Public Health Agency of Canada, issuing body. |
|---|---|
| Titre | Evaluation of the Pharmaceutical Drugs Program / prepared by the Office of Audit and Evaluation, Health Canada and the Public Health Agency of Canada. |
| Type de publication | Monographie |
| Langue | [Anglais] |
| Autres langues publiées | [Français] |
| Format | Électronique |
| Document électronique | |
| Note(s) | Issued also in French under title: Évaluation du Programme des médicaments pharmaceutiques. Includes bibiographical references (pages [pages 8-11]). |
| Information sur la publication | [Ottawa] : Health Canada, Public Health Agency of Canada = Santé Canada, l'Agence de la santé publique du Canada, January 2024. ©2024 |
| Description | 1 online resource (ii, vi, 38, [11] pages) : charts |
| ISBN | 9780660722801 |
| Numéro de catalogue |
|
| Numéro de catalogue du ministère | 240263 |
| Descripteurs | Canada. Health Canada -- Evaluation. Public Health Agency of Canada -- Evaluation. Pharmaceutical policy -- Canada -- Evaluation. |
Demander des formats alternatifs
Pour demander une publication dans un format alternatif, remplissez le formulaire électronique des publications du gouvernement du Canada. Utilisez le champ du formulaire «question ou commentaire» pour spécifier la publication demandée.- Date de modification :